Davide Ferorelli

Dr. Davide Ferorelli

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
PDF file
DFDavide Ferorelli
Davide Ferorelli
LNL. Nardelli
L. Nardelli
LSL. Spagnolo
L. Spagnolo
SCS. Corradi
S. Corradi
MSM. Silvestre
M. Silvestre
ADA. Dell’eRba
A. Dell’eRba
Telemedicine services can be classified into the macro-categories of specialist Telemedicine, Tele-health and Tele-assistance. From a regulatory perspective, in Italy, the first provision dedicated to the implementation of Telemedicine services is represented by the Agreement between the Government and the Regions on the document bearing “Telemedicine—National guidelines,” approved by the General Assembly of the Superior Health Council in the session of 10th July 2012 and by the State Regions Conference in the session of 20th February 2014. Scientifically, several studies in the literature state that information and communication technologies have great potential to reduce the costs of health care services in terms of planning and making appropriate decisions that provide timely tools to patients. Another clear benefit is the equity of access to health care. The evolution of telemedicine poses a series of legal problems ranging from the profiles on the subject of authorization and accreditation to those concerning the protection of patient confidentiality, the definition and solution of which, in the absence of specific regulatory provisions, is mainly left to the assessment of compatibility of the practices adopted so far, with the general regulatory framework. In terms of professional liability, it is necessary to first clarify that the telemedicine service is comparable to any diagnostic-therapeutic health service considering that the telemedicine service does not replace the traditional health service, but integrates the latter to improve its effectiveness, efficiency and appropriateness.

1 July 2020 in Journal of Hospital Infection
Verified
Journal Article
Open access
Luigi VimercatiLuigi Vimercati
Luigi Vimercati
ADA. Dell’eRba
A. Dell’eRba
GMG. Migliore
G. Migliore
LML. De Maria
L. De Maria
Antonio CaputiAntonio Caputi
Antonio Caputi
Silvio TafuriSilvio Tafuri
Silvio Tafuri
SARS-CoV-2-related SARIs (severe acute respiratory infections) have a major impact on public health; moreover, healthcare workers (HCWs) are exposed to a high biological risk. The aim of this study was to show the prevention procedures in place in the University Hospital of Bari (Apulia Region, Southern Italy) to reduce this risk to HCWs, consisting of the enhancement of preventive measures and the activation of a report system to collect HCWs' contacts. To date, 23 confirmed cases of infections (0.4% of all HCWs) have been reported in a 30-day observation period. These results show that correct management of HCWs' contacts is essential to avoid nosocomial clusters.

7 October 2019 in Vaccines
Verified
Journal Article
Open access
PDF file
PSPasquale Stefanizzi
Pasquale Stefanizzi
PSPaolo Stella
Paolo Stella
DADomenica Ancona
Domenica Ancona
KMKatia Nicoletta Malcangi
Katia Nicoletta Malcangi
FBFrancesco Paolo Bianchi
Francesco Paolo Bianchi
Silvio TafuriSilvio Tafuri
Silvio Tafuri
Since 2012, the Italian Ministry of Health has recommended to improve the surveillance of adverse events following the measles-mumps-rubella-varicella (MMRV) tetravalent vaccine that was provided in the official immunization schedule of some Italian regions for children during the second year of life. This recommendation was based on data from some surveys that showed an additional risk of seizure following the administration of this vaccine. Responding to the Ministry commitment, the Puglia Region launched, from May 2017 to November 2018, a post-marketing active surveillance program of adverse events following MMRV immunization (AEFIs). Immunized children (second year of life) were enrolled on a voluntary basis, AEFIs diaries were used, and their parents were interviewed 25 days after the immunization. There were 2540 children enrolled; 2149/2540 (84.6%) completed the post-vaccination follow-up. Of these, 992 AEFIs were registered with a reporting rate of 46.2 × 100 doses: 883/992 (89.0%) AEFIs were not serious, while 109/992 (11.0%) were serious. For serious AEFIs, the evaluation of causality assessment was performed using the algorithm proposed by the World Health Organisation (WHO): 82/109 consistent causal associations to MMRV immunization were detected (reporting rate of consistent AEFIs: 3.8 × 100 follow-up). All serious AEFIs consistently associated with immunization resulted completely resolved at the follow-up. The reporting rate of seizure consistently associated with immunization was 0.05 × 100, lower than data previous published in the literature that did not report the causality assessment. Because no emerging signals were detected, our data from the active surveillance program confirmed the safety profile of the MMRV vaccine.

1 October 2025 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
GPGianmarco Di Palma
Gianmarco Di Palma
Roberto ScendoniRoberto Scendoni
Roberto Scendoni
DFDavide Ferorelli
Davide Ferorelli
Anna De BenedictisAnna De Benedictis
Anna De Benedictis
VTVittoradolfo Tambone
Vittoradolfo Tambone
Francesco De MiccoFrancesco De Micco
Francesco De Micco
Background/Objectives: Artificial intelligence (AI) is revolutionizing the healthcare industry, improving diagnoses, treatments, and clinical processes. However, its integration poses significant cybersecurity risks, including data breaches, algorithmic opacity, and vulnerabilities in AI-controlled medical devices. This narrative review analyzes these threats and evaluates blockchain technology as a potential mitigation strategy within a Clinical Risk Management framework. Methods: The literature search was conducted on PubMed, Scopus, and Web of Science, considering peer-reviewed publications from 2000 to January 2025. 1,204 articles were identified. Inclusion criteria included studies on cybersecurity risks in healthcare, blockchain applications in the clinical setting, and regulatory references (eg, General Data Protection Regulation). Conference abstracts, non-English articles, and non-peer-reviewed contributions were excluded. To ensure methodological rigor, the Scale for the Assessment of Narrative Review Articles criteria were applied. Results: The thematic analysis highlighted recurring critical issues: difficulties with informed consent, unauthorized access to sensitive data, and systemic vulnerabilities in hospital digital infrastructures. Blockchain presents a promising solution thanks to its decentralization, immutability, and transparency. Integration with smart contracts enables dynamic consent management, secure data sharing, and real-time monitoring of medical devices. Permissioned networks improve traceability and regulatory compliance, while Layer 2 solutions and optimized consent protocols address scalability challenges. Conclusion: Despite its potential, blockchain adoption faces obstacles: high costs, regulatory rigidity, and poor acceptance among healthcare professionals. The review highlights the need for pilot projects, interdisciplinary collaboration, and regulatory updates for effective integration. Combining AI and blockchain in Clinical Risk Management can transform clinical risk management from reactive to proactive, improving patient safety, data governance, and accountability.

DFDavide Ferorelli
Davide Ferorelli
Biagio SolarinoBiagio Solarino
Biagio Solarino
STSilvia Trotta
Silvia Trotta
GMGabriele Mandarelli
Gabriele Mandarelli
LTLucia Tattoli
Lucia Tattoli
ADAlessandro Dell’erba
Alessandro Dell’erba
Clinical risk management constitutes a central element in the healthcare systems in relation to the reverberation that it establishes, and as regards the optimization of clinical outcomes for the patient. The starting point for a right clinical risk management is represented by the identification of non-conforming results. The aim of the study is to carry out a systematic analysis of all data received in the first three years of adoption of a reporting system, revealing the strengths and weaknesses. The results emerged showed an increasing trend in the number of total records. Notably, 86.0% of the records came from the medical category. Moreover, 41.0% of the records reported the possible preventive measures that could have averted the event and in 30% of the reports are hints to be put in place to avoid the repetition of the events. The second experimental phase is categorizing the events reported. Implementing the reporting system, it would guarantee a virtuous cycle of learning, training and reallocation of resources. By sensitizing health workers to a correct use of the incident reporting system, it could become a virtuous error learning system. All this would lead to a reduction in litigation and an implementation of the therapeutic doctor–patient alliance.

11 December 2020 in Medicina
Verified
Journal Article
Open access
PDF file
DFDavide Ferorelli
Davide Ferorelli
GMGabriele Mandarelli
Gabriele Mandarelli
Biagio SolarinoBiagio Solarino
Biagio Solarino
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, Italy has proven to be one of the countries with the highest coronavirus-linked death rate. To reduce the impact of SARS-CoV-2 coronavirus, the Italian Government decision-makers issued a series of law decrees that imposed measures limiting social contacts, stopped non-essential production activities, and restructured public health care in order to privilege assistance to patients infected with SARS-CoV-2. Health care services were substantially limited including planned hospitalization and elective surgeries. These substantial measures were criticized due to their impact on individual rights including freedom and autonomy, but were justified by the awareness that hospitals would have been unable to cope with the surge of infected people who needed treatment for COVID-19. The imbalance between the need to guarantee ordinary care and to deal with the pandemic, in a context of limited health resources, raises ethical concerns as well as clinical management issues. The emergency scenario caused by the COVID-19 pandemic, especially in the lockdown phase, led the Government and health care decision-makers to prioritize community safety above the individuals’ rights. This new community-centered approach to clinical care has created tension among the practitioners and exposed health workers to malpractice claims. Reducing the morbidity and mortality rates of the COVID-19 pandemic is the priority of every government, but the legitimate question remains whether the policy that supports this measure could be less harmful for the health care system.